These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34028505)

  • 1. Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease.
    Kanwal F; Hernaez R; Liu Y; Taylor TJ; Rana A; Kramer JR; Naik AD; Smith D; Taddei T; Asch SM
    JAMA Intern Med; 2021 Jul; 181(7):949-959. PubMed ID: 34028505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
    JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.
    Goldberg D; French B; Newcomb C; Liu Q; Sahota G; Wallace AE; Forde KA; Lewis JD; Halpern SD
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1638-1646.e2. PubMed ID: 27374003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas.
    Axelrod DA; Guidinger MK; Finlayson S; Schaubel DE; Goodman DC; Chobanian M; Merion RM
    JAMA; 2008 Jan; 299(2):202-7. PubMed ID: 18182602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients From Appalachia Have Reduced Access to Liver Transplantation After Wait-Listing.
    Beal EW; Tumin D; Sobotka L; Tobias JD; Hayes D; Pawlik TM; Washburn K; Mumtaz K; Conteh L; Black SM
    Prog Transplant; 2018 Dec; 28(4):305-313. PubMed ID: 30205758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.
    Yilma M; Kim NJ; Shui AM; Tana M; Landis C; Chen A; Bangaru S; Mehta N; Zhou K
    JAMA Netw Open; 2023 Jun; 6(6):e2317549. PubMed ID: 37289453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States.
    Nephew LD; Mosesso K; Desai A; Ghabril M; Orman ES; Patidar KR; Kubal C; Noureddin M; Chalasani N
    JAMA Netw Open; 2020 Oct; 3(10):e2019869. PubMed ID: 33030554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
    Gutin L; Yao F; Dodge JL; Grab J; Mehta N
    JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS
    Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Disparity in Liver Transplantation Listing.
    Warren C; Carpenter AM; Neal D; Andreoni K; Sarosi G; Zarrinpar A
    J Am Coll Surg; 2021 Apr; 232(4):526-534. PubMed ID: 33444709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Dialysis Facility Ownership and Access to the Waiting List and Transplant in Pediatric Patients With End-stage Kidney Disease in the US.
    Amaral S; McCulloch CE; Lin F; Grimes BA; Furth S; Warady B; Brunson C; Siyahian S; Ku E
    JAMA; 2022 Aug; 328(5):451-459. PubMed ID: 35916847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.
    Goldberg DS; French B; Forde KA; Groeneveld PW; Bittermann T; Backus L; Halpern SD; Kaplan DE
    JAMA; 2014 Mar; 311(12):1234-43. PubMed ID: 24668105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.
    Leung DH; Narang A; Minard CG; Hiremath G; Goss JA; Shepherd R
    Liver Transpl; 2016 Nov; 22(11):1584-1592. PubMed ID: 27541809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
    Alshuwaykh O; Kwong A; Goel A; Cheung A; Dhanasekaran R; Ahmed A; Daugherty T; Dronamraju D; Kumari R; Kim WR; Nguyen MH; Esquivel CO; Concepcion W; Melcher M; Bonham A; Pham T; Gallo A; Kwo PY
    Hepatol Commun; 2021 Mar; 5(3):516-525. PubMed ID: 33681683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.
    Martel-Laferrière V; Michel A; Schaefer S; Bindal S; Bichoupan K; Branch AD; Huprikar S; Schiano TD; Perumalswami PV
    Transpl Infect Dis; 2015 Aug; 17(4):527-35. PubMed ID: 25929731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.